Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction - MI3 Trial

Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction - MI3 Trial

Background & objectives: Acute myocardial infarction (AMI) is characterized by irreparable and irreversible loss of cardiac myocytes. Despite major advances in the management of AMI, a large number of patients are left with reduced left ventricular ejection fraction (LVEF), which is a major dete...

Full description

Bibliographic Details
Main Authors: Velu Nair, Hemant Madan, Sunil Sofat, Prosenjit Ganguli, M J Jacob, Rajat Datta, Prashant Bharadwaj, R S Sarkar, A J Pandit, Soniya Nityanand, Pravin K Goel, Naveen Garg, Sanjay Gambhir, Paul V George, Sunil Chandy, Vikram Mathews, Oomen K George, K K Talwar, Ajay Bahl, Neelam Marwah, Anish Bhatacharya, Balram Bhargava, Balram Airan, Sujata Mohanty, Chetan D Patel, Alka Sharma, Shinjini Bhatnagar, A Mondal, Jacob Jose, A Srivastava, MI3 Trial
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Medical Research
Subjects:
Acute myocardial infarction - autologous bone marrow derived mononuclear cells - left ventricular ejection fraction - MI3: mononuclear infusion in myocardial infarction - multicentrial-trial in India - stem cell therapy
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=142;issue=2;spage=165;epage=174;aulast=Nair

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=142;issue=2;spage=165;epage=174;aulast=Nair

Similar Items